Experienced in IgG4-Related Disease

Dr. Omar A. Alkharabsheh

Hematology Oncology | Hematology | Oncology
Usa Health - Mci Business Services LLC
1660 Spring Hill Ave, 
Mobile, AL 
Accepting New Patients

Experienced in IgG4-Related Disease
Usa Health - Mci Business Services LLC
1660 Spring Hill Ave, 
Mobile, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Omar Alkharabsheh is a Hematologist Oncology specialist and a Hematologist in Mobile, Alabama. Dr. Alkharabsheh is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Thrombocytopenia, and Anemia. Dr. Alkharabsheh is currently accepting new patients.

His clinical research consists of co-authoring 27 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MN
Hospital Affiliations
Usa Health University Hospital
Usa Health Children's & Women's Hospital
University Of Cincinnati Medical Center, LLC
Thomas Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

USA HEALTH - MCI BUSINESS SERVICES LLC
1660 Spring Hill Ave, Mobile, AL 36604
Call: 251-665-8000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
View 2 Less Clinical Trials

27 Total Publications

Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals.
Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals.
Journal: Cancers
Published: September 19, 2025
View All 27 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Solly S. Chedid
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Solly S. Chedid
Hematology Oncology | Hematology | Oncology

Singing River Health System

2809 Denny Ave, 
Pascagoula, MS 
 (34.9 miles away)
228-818-0563
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Solly Chedid is a Hematologist Oncology specialist and a Hematologist in Pascagoula, Mississippi. Dr. Chedid is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Pseudomyxoma Peritonei, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Pancreatic Cancer. Dr. Chedid is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. John R. Schaub
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. John R. Schaub
Hematology Oncology | Hematology | Oncology

Woodlands Medical Specialists P A

4724 N Davis Hwy, 
Pensacola, FL 
 (53.2 miles away)
850-696-4000
Experience:
10+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Schaub is a Hematologist Oncology specialist and a Hematologist in Pensacola, Florida. Dr. Schaub has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Morning Sickness, and Thrombocytopenia. Dr. Schaub is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alkharabsheh's expertise for a condition
ConditionClose
    • Distinguished
    • Multiple Myeloma
      Dr. Alkharabsheh is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Relapsed Refractory Multiple Myeloma (RRMM)
      Dr. Alkharabsheh is
      Distinguished
      . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
      See more Relapsed Refractory Multiple Myeloma (RRMM) experts
    • Advanced
    • Acute Mountain Sickness
      Dr. Alkharabsheh is
      Advanced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Alkharabsheh is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Alkharabsheh is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Alkharabsheh is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Immune Thrombocytopenia
      Dr. Alkharabsheh is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Agranulocytosis
      Dr. Alkharabsheh is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    View All 43 Advanced Conditions
    • Experienced
    • Acute Erythroid Leukemia (AEL)
      Dr. Alkharabsheh is
      Experienced
      . Learn about Acute Erythroid Leukemia (AEL).
      See more Acute Erythroid Leukemia (AEL) experts
    • Acute Hepatic Porphyria (AHP)
      Dr. Alkharabsheh is
      Experienced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Alkharabsheh is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Monoblastic Leukemia (AmoL)
      Dr. Alkharabsheh is
      Experienced
      . Learn about Acute Monoblastic Leukemia (AmoL).
      See more Acute Monoblastic Leukemia (AmoL) experts
    • Acute Promyelocytic Leukemia
      Dr. Alkharabsheh is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adrenal Cancer
      Dr. Alkharabsheh is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    View All 173 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved